AstraZeneca polyneuropathy treatment recommended for EU approval
(Alliance News) - AstraZeneca PLC on Monday said its Wainzua treatment has been been recommended for EU approval to treat adult patients with polyneuropathy associated with hereditary transthyretin-mediated amyloidosis. Read More